Venture Capital
-
UNSW Canberra backs the ACTivate Capital Fund
The ACTivate Capital Fund was set up by the government of the Australian Capital Territory to invest in startups and spinouts in Canberra.
-
Breakthrough Victoria backs the SYNthesis BioVentures Fund I
Created by Monash University’s Prof Andrew Wilks, the SYNthesis BioVentures Fund I works with Australian research institutes to scale their spinouts.
-
Creator Fund raises $41 million for pan-European fund
The venture fund targets startups built by PhD students, and Creator Fund is targeting a $55 million final close by early 2026.
-
Robert Langer, prolific MIT spinout founder, launches $77.5 million fund
T.Rx Capital has closed its inaugural fund at $77.5 million to build and invest in healthcare startups, with Langer’s son also among the firm’s co-founders.
-
Venture Investors Health Fund raises $80 million to back spinouts
Venture Investors Health Fund has secured $80 million to invest in spinouts from institutions such as the University of Michigan.
-
Brandon Capital collects A$439 million for sixth fund
Australasian life sciences VC Brandon Capital has a partnership with more than 50 research institutions that provide access to deals.
-
Catalio closes Nexus Fund IV with $400 million
Catalio Capital Management specialises in launching and investing in life sciences spinouts through a network of researchers that act as venture partners.